UPDATE 1-Branded drugs help Botox-maker Allergan beat profit estimates

Nov 4 (Reuters) - Allergan Plc, created from the merger of Actavis and Allergan, reported a better-than-expected quarterly profit on strong sales of high-margin branded drugs, its biggest business.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.